Dimethyl fumarate
Tecfidera, Skilarence (dimethyl fumarate) is a small molecule pharmaceutical. Dimethyl fumarate was first approved as Tecfidera on 2013-03-27. It has been approved in Europe to treat multiple sclerosis and psoriasis. Tecfidera's patents are valid until 2035-11-16 (FDA).
| Trade Name | Skilarence, Tecfidera |
|---|---|
| Common Name | Dimethyl fumarate |
| Indication | multiple sclerosis, psoriasis |
| Drug Class |
